On Tuesday, Essa Pharma Inc (NASDAQ: EPIX) opened lower -3.01% from the last session, before settling in for the closing price of $1.66. Price fluctuations for EPIX have ranged from $1.40 to $10.94 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted 7.81% at the time writing. With a float of $43.37 million, this company’s outstanding shares have now reached $44.39 million.
Considering the fact that the conglomerate employs 35 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Essa Pharma Inc (EPIX) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Essa Pharma Inc is 2.24%, while institutional ownership is 99.04%. The most recent insider transaction that took place on Nov 01 ’24, was worth 12,018,409. In this transaction 10% Owner of this company sold 7,879,583 shares at a rate of $1.53, taking the stock ownership to the 0 shares. Before that another transaction happened on Oct 07 ’24, when Company’s Chief Operating Officer sold 694 for $6.03, making the entire transaction worth $4,185. This insider now owns 7,776 shares in total.
Essa Pharma Inc (EPIX) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.12 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 7.81% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 8.52% during the next five years compared to 15.68% growth over the previous five years of trading.
Essa Pharma Inc (NASDAQ: EPIX) Trading Performance Indicators
Check out the current performance indicators for Essa Pharma Inc (EPIX). In the past quarter, the stock posted a quick ratio of 38.64.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.64, a number that is poised to hit -0.15 in the next quarter and is forecasted to reach -0.49 in one year’s time.
Technical Analysis of Essa Pharma Inc (EPIX)
Compared to the last year’s volume of 0.23 million, its volume of 0.26 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 13.20%. Additionally, its Average True Range was 0.08.
During the past 100 days, Essa Pharma Inc’s (EPIX) raw stochastic average was set at 3.82%, which indicates a significant decrease from 16.67% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 23.66% in the past 14 days, which was lower than the 214.79% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.7197, while its 200-day Moving Average is $4.3407. Nevertheless, the first resistance level for the watch stands at $1.6967 in the near term. At $1.7833, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.8467. If the price goes on to break the first support level at $1.5467, it is likely to go to the next support level at $1.4833. Should the price break the second support level, the third support level stands at $1.3967.
Essa Pharma Inc (NASDAQ: EPIX) Key Stats
There are currently 44,389K shares outstanding in the company with a market cap of 71.46 million. Presently, the company’s annual sales total 0 K according to its annual income of -28,540 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -6,360 K.
